MedMemos: An Intervention to Promote Medication Adherence in Pediatric Allogenic Hematopoietic Stem Cell Transplantation
The goal of this clinical trial is to test the MedMemos Intervention with parents and children who have received a bone marrow transplant. The main study questions are: * Is the MedMemos intervention acceptable to patients and families? * Is the MedMemos intervention feasible for patients, families, and healthcare providers? * Does MedMemos help patients and families take their medications better? Participants will be asked to complete surveys, attend 4 intervention sessions, and use an electronic box or pill bottle to store their medications in.
• Child had a Pediatric Allogeneic Hematopoietic Cell Transplant (PAHCT)
• Child is 0-12 years of age
• At the time of recruitment child is still in the hospital for PAHCT
• Child's primary caregiver is responsible for administering medical care and is willing to give consent to participate
• Child is prescribed an oral medication regimen at discharge